Trial Site Detail
Drug: |
Imatinib + RAD001 |
|||
|---|---|---|---|---|
Trial: |
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
UCLA's Jonsson Comprehensive Cancer Center10945 Le Conte Ave. |
Principal Investigator: |
J. Randolph Hecht |
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
UCLA's Jonsson Comprehensive Cancer Center Website: |
http://www.cancer.ucla.edu/Index.aspx?page=51 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.